S Simon

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Cancer statistics, 2022

Teenage acne and cancer risk in US women: A prospective cohort study

Cancer statistics, 2023

Multidrug resistance in cancer: role of ATP–dependent transporters

Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.

Cancer statistics, 2020

Cancer statistics, 2024

Cancer Statistics, 2021

From traditional Chinese medicine to rational cancer therapy

mRNA vaccines — a new era in vaccinology

Triggering and modulation of apoptosis by oxidative stress

The Generation R Study: design and cohort update 2010

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials

Cancer Statistics, 2006

Targeting multidrug resistance in cancer

Phase I trial of sequential topotecan followed by etoposide in adults with myeloid leukemia: a National Cancer Institute of Canada Clinical Trials Group Study

Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia

Homoharringtonine in combination with cytarabine and aclarubicin resulted in high complete remission rate after the first induction therapy in patients with de novo acute myeloid leukemia

Paul Ehrlich's magic bullet concept: 100 years of progress

Targeting DNA topoisomerase II in cancer chemotherapy

Acute Myeloid Leukemia

Cancer as an evolutionary and ecological process

Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer

Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor and Ara-C exert synergistic toxicity against human AML HL-60 cells

Autologous peripheral blood stem cell transplantation for acute myeloid leukemia

Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33‐positive acute myeloid leukemia in first recurrence

Superoxide Dismutases: Role in Redox Signaling, Vascular Function, and Diseases

Wound repair and regeneration: Mechanisms, signaling, and translation

Secretion of extracellular superoxide dismutase from muscle transduced with recombinant adenovirus inhibits the growth of B16 melanomas in mice.

Acute Myeloid Leukemia

A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients

Patients With t(8;21)(q22;q22) and Acute Myeloid Leukemia Have Superior Failure-Free and Overall Survival When Repetitive Cycles of High-Dose Cytarabine Are Administered

Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias

High‐dose cytosine arabinoside in the treatment of acute myeloid leukemia

Toward the potential cure of leukemias in the next decade

Combination therapy in combating cancer

Cancer treatment and survivorship statistics, 2016

Immune responses and long‐term disease recurrence status after telomerase‐based dendritic cell immunotherapy in patients with acute myeloid leukemia

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials

A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia

Cancer treatment and survivorship statistics, 2019

Effect of Diagnosis (Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation, or Acute Myeloid Leukemia [AML]) on Outcome of AML-Type Chemotherapy

Systematic Review of Barriers to the Recruitment of Older Patients With Cancer Onto Clinical Trials

WP-1034, a novel JAK-STAT inhibitor, with proapoptotic and antileukemic activity in acute myeloid leukemia (AML).

The World Health Organization (WHO) classification of the myeloid neoplasms

Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML

Sense and nonsense of high-dose cytarabine for acute myeloid leukemia

Hormonal Influences on Growth of B16 Murine Melanoma<xref ref-type="fn" rid="FN2">2</xref>

A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study